Turna Ray

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.

The regulations have received a tepid reception from some doctors worried about patients finding out sensitive information online without support.

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.

Researchers used real-world data to identify low NGS testing rates, particularly among Black patients, suggesting many aren't getting precision medical treatment.

In IMpower010, Tecentriq significantly reduced the risk of death or disease recurrence in patients with stage II to IIIA tumors, particularly in those with PD-L1 expression.

The treatment combined with standard-of-care therapies lowered the risk of death by 38 percent in PSMA-positive, refractory prostate cancer patients.

At ASCO, the company detailed its efforts to make the 93-SNP riskScore, which it plans to offer as a standalone DTC test next year, relevant for women of all ancestries.

Between June 2019 and June 2020, regulatory authorities from participating countries approved 38 cancer drugs, 10 of which were for molecularly defined indications.

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.

The California health system is working with Canexia to assess if a triaged, in-house testing strategy improves outcomes, lowers cost, and reduces access inequities.